magnesium sulfate 0.0467 MG/ML
- RxCUI
- 1111742
- RxNorm name
- magnesium sulfate 0.0467 MG/ML
- Term type
- SCDC
- Status
- Active
- Updated
- 2026-06-16 07:07:56
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 072011
- Active start
- 072011
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 0.0467 MG / 1 ML | magnesium sulfate |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| magnesium sulfate | 6585 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | magnesium sulfate 0.0467 MG/ML | NAMES |
| RxNorm Name | magnesium sulfate 0.0467 MG/ML | NAMES |
| TTY | SCDC | ATTRIBUTES |
| RxCUI | 1111742 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | B05XA | Electrolyte solutions | ATC1-4 | magnesium sulfate | |
| ATC | A12CC | Magnesium | ATC1-4 | magnesium sulfate | |
| ATC | A06AD | Osmotically acting laxatives | ATC1-4 | magnesium sulfate | |
| ATC | D11AX | Other dermatologicals | ATC1-4 | magnesium sulfate | |
| ATC | V04CC | Tests for bile duct patency | ATC1-4 | magnesium sulfate | |
| MEDRT | D008278 | Magnesium Sulfate | CHEM | has_ingredient | magnesium sulfate |
| MEDRT | D000224 | Addison Disease | DISEASE | ci_with | magnesium sulfate |
| MEDRT | D003248 | Constipation | DISEASE | may_treat | magnesium sulfate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | magnesium sulfate |
| MEDRT | D004461 | Eclampsia | DISEASE | may_treat | magnesium sulfate |
| MEDRT | D006327 | Heart Block | DISEASE | ci_with | magnesium sulfate |
| MEDRT | D006505 | Hepatitis | DISEASE | ci_with | magnesium sulfate |
| MEDRT | D008275 | Magnesium Deficiency | DISEASE | may_prevent | magnesium sulfate |
| MEDRT | D008275 | Magnesium Deficiency | DISEASE | may_treat | magnesium sulfate |
| MEDRT | D009393 | Nephritis | DISEASE | may_treat | magnesium sulfate |
| MEDRT | D011225 | Pre-Eclampsia | DISEASE | may_treat | magnesium sulfate |
| MEDRT | D051437 | Renal Insufficiency | DISEASE | ci_with | magnesium sulfate |
| MEDRT | D012640 | Seizures | DISEASE | may_prevent | magnesium sulfate |
| MEDRT | D012640 | Seizures | DISEASE | may_treat | magnesium sulfate |
| MEDRT | D016171 | Torsades de Pointes | DISEASE | may_treat | magnesium sulfate |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | magnesium sulfate |
| MEDRT | N0000000226 | Acid-Base Activity | MOA | has_moa | magnesium sulfate |
| MEDRT | N0000000220 | Electrolyte Activity | MOA | has_moa | magnesium sulfate |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | magnesium sulfate |
| MEDRT | N0000008303 | Atrial Repolarization | PE | has_pe | magnesium sulfate |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | magnesium sulfate |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | magnesium sulfate |
| MEDRT | N0000008453 | Decreased Cardiac Muscle Acetylcholine Activity | PE | has_pe | magnesium sulfate |
| MEDRT | N0000008735 | Decreased Muscular System Acetylcholine Activity | PE | has_pe | magnesium sulfate |
| MEDRT | N0000009329 | Increased GI Motility | PE | has_pe | magnesium sulfate |
| MEDRT | N0000009933 | Increased Vitamin Uptake and Modification | PE | has_pe | magnesium sulfate |
| MEDRT | N0000009845 | Small Intestine Fluid/Electrolyte Absorption Alteration | PE | has_pe | magnesium sulfate |
| MEDRT | N0000009870 | Stimulation Large Intestine Fluid/Electrolyte Absorption | PE | has_pe | magnesium sulfate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | HYBRID |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | STRENGTH | 0.0467 MG/ML |
| ATTRIBUTES | TTY | SCDC |
| CODES | RxCUI | 1111742 |
| NAMES | RXNAV_STR | magnesium sulfate 0.0467 MG/ML |
| NAMES | RxNorm Name | magnesium sulfate 0.0467 MG/ML |